Xenix Medical announces FDA clearance and full commercial launch of the Lux System

Regulatory Approvals
Xenix Medical announced FDA 510(k) clearance and full commercial launch for its Lux Expandable Lumbar Interbody Fusion System. Lux is the result of strong market demand for an expandable interbody fusion device that does not...

Xenix Medical announces FDA clearance and full commercial launch of the Lux System

Regulatory Approvals
Xenix Medical announced FDA 510(k) clearance and full commercial launch for its Lux Expandable Lumbar Interbody Fusion System. Lux is the result of strong market...

Anteris to expand global heart valve trial

Clinical Trials
Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Clinical Trials
Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Kalogon raises $5.75M to make sitting healthier for all

Funding
Kalogon, the market leader in smart seating solutions, announced it has raised $5.75 million in funding to accelerate further global expansion of its seating...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Anteris to expand global heart valve trial

Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Picard Medical’s SynCardia completes milestone study of next-gen total artificial heart

Picard Medical, parent company of SynCardia, announced the completion of an in vivo study of its Emperor platform. The company completed an acute in vivo...

Reflow Medical has positive data for coronary drug-eluting stent

Reflow Medical announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system. San Clemente, California-based Reflow designed its...

Innovation

Regulatory Approvals

Xenix Medical announces FDA clearance and full commercial launch of the Lux System

Xenix Medical announced FDA 510(k) clearance and full commercial launch for its Lux Expandable Lumbar Interbody Fusion System. Lux is the result of strong market...

Anteris to expand global heart valve trial

Anteris Technologies announced that it received full regulatory clearance to expand its PARADIGM trial to France. The company - founded in Brisbane, Australia with a...

Neuronoff implants first patient in DOD-funded trial of Injectrode

Neuronoff, a clinical-stage neuromodulation company, announced the first patient implant in a Department of Defense (DOD) funded clinical trial evaluating the safety and efficacy...

Kalogon raises $5.75M to make sitting healthier for all

Kalogon, the market leader in smart seating solutions, announced it has raised $5.75 million in funding to accelerate further global expansion of its seating...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1151Regulatory Approvals1022Innovation655Clinical Trials525Mergers & Acquisitions509GS Funding Tracker52